COST ACCOUNTING
TRANSFER PRICING
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
|
|
GSK
|
|
|
Syngenta
|
|
|
Novartis
|
|
|
BP
|
Detailed explanation-1: -To increase its U.S. presence, Novartis will adopt a “U.S.-first mindset, ” increasing the share of U.S. patients in clinical trials and “building capability and talent” in the country, the company said.
Detailed explanation-2: -two key areas of CSR at Novartis: first, expanding access to healthcare and second, doing business responsibly.
Detailed explanation-3: -The company gained its competitive advantage by developing a diversified portfolio of pharmaceuticals, focusing on improving margins, and delivering high-quality drugs in the market.
Detailed explanation-4: -Novartis was created in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis and its predecessor companies trace roots back more than 250 years, with a rich history of developing innovative products.